Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Argent Biopharma (AU:RGT)
ASX:RGT
Holding AU:RGT?
Track your performance easily
RGT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.15 - AU$0.57
Previous CloseN/A
Volume362.25K
Average Volume (3M)55.43K
Market Cap
$12.74M
Enterprise ValueAU$21.93M
Total Cash (Recent Filing)$11.36M
Total Debt (Recent Filing)$20.31K
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding59,272,270
10 Day Avg. Volume132,446
30 Day Avg. Volume55,430
Standard Deviation0.38
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)102.63
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market Cap1.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit107.68
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Argent Biopharma News
PremiumCompany Announcements
Argent BioPharma Issues 5 Million Shares Under Regulatory Exemption
PremiumCompany Announcements
Argent Biopharma Issues 2.5 Million Unlisted Warrants
PremiumCompany Announcements
Argent Biopharma Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Argent Biopharma to Issue New Securities for Growth
PremiumCompany Announcements
Argent Biopharma Proposes New Securities Issue to Bolster Market Position
PremiumCompany Announcements
Argent BioPharma Secures $4.5M for Drug Development and Strategic Expansion
PremiumCompany Announcements
Argent BioPharma Prepares for Major Capital Raising
PremiumCompany Announcements
Argent Biopharma to Delist from London Stock ExchangeOptions Prices
Currently, No data available
---
Ownership Overview
RGT FAQ
What was Argent Biopharma’s price range in the past 12 months?
Argent Biopharma lowest share price was AU$0.15 and its highest was AU$0.57 in the past 12 months.
What is Argent Biopharma’s market cap?
Argent Biopharma’s market cap is $12.74M.
When is Argent Biopharma’s upcoming earnings report date?
Argent Biopharma’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were Argent Biopharma’s earnings last quarter?
Argent Biopharma released its earnings results on Aug 30, 2024. The company reported -AU$0.231 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.231.
Is Argent Biopharma overvalued?
According to Wall Street analysts Argent Biopharma’s price is currently Overvalued.
Does Argent Biopharma pay dividends?
Argent Biopharma does not currently pay dividends.
What is Argent Biopharma’s EPS estimate?
Argent Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Argent Biopharma have?
Argent Biopharma has 59,272,270 shares outstanding.
What happened to Argent Biopharma’s price movement after its last earnings report?
Argent Biopharma reported an EPS of -AU$0.231 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.576%.
Which hedge fund is a major shareholder of Argent Biopharma?
Currently, no hedge funds are holding shares in AU:RGT
---
Argent Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:RGT Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.41%
Trailing 12-Months
Company Description
Argent Biopharma
MGC Pharmaceuticals Ltd is a European-based specialist Medical Cannabis company, in Phytocannabinoid-based medicine within the biopharmaceutical industry. The company's principal business goal is to produces and supply quality Cannabinoid based pharmaceutical products for the emergent medical markets in Europe, North America and Australasia.
---
Technical Analysis
CSL
―
Cochlear Limited
―
Ramsay Health Care
―
Sonic Healthcare Limited
―
Fluence Corporation Limited
―
---